Ignite Creation Date:
2024-05-06 @ 4:09 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04896684
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2021-05-03
Brief Title:
Chronic Intestinal Pathologies Analytical Cohort at TouLouse
Sponsor:
University Hospital Toulouse
Organization:
University Hospital Toulouse
Study Overview
Official Title:
Chronic Intestinal Pathologies Analytical Cohort at TouLouse
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPITOL
Brief Summary:
In the general population the percentage of people with at least one digestive disease is 167 Among these digestive diseases inflammatory bowel disease IBD irritable bowel syndrome IBS and patients who should benefit from digestive examinations as part of a screening oriented either by the patients family history or following the performance of an immunological screening test FIT in the stool will be studied The aim of this project is to build a biological collection with associated clinical data for research projects
Detailed Description:
In the general population the percentage of people with at least one digestive disease is 167 Among these digestive diseases two of them namely inflammatory bowel disease IBD and irritable bowel syndrome IBS will be more particularly studied This interest is based on the increasing frequency of these two pathologies their chronicities but above all the limited physiopathological data available In addition it seems interesting to study a third population namely patients who should benefit from digestive examinations as part of a screening oriented either by the patients family history or following the performance of an immunological screening test FIT in the stool The study of this population is part of an improvement in knowledge on the carcinogenesis of colorectal cancer
To study these populations blood serum plasma and tissues from colonous biopsies or surgical samples will be collected
This cohort will make it possible to study among other things the pathophysiology of chronic diseases of the small intestine and the colon IBD IBS screening in order to improve their management through the development of new biomarkers and therapeutic targets
To study these populations blood serum plasma and tissues from colonous biopsies or surgical samples will be collected
This cohort will make it possible to study among other things the pathophysiology of chronic diseases of the small intestine and the colon IBD IBS screening in order to improve their management through the development of new biomarkers and therapeutic targets
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None